Buy Claris Lifesciences, Target Price Rs 250: G Chokkalingam

G Chokkalingam, founder of Equinomics Research & Advisory, recommends buying Claris Lifesciences shares. Claris is a zero-debt company and its valuations are at attractive levels, he adds.

Related Videos